I 
117TH CONGRESS 
2D SESSION 
H. R. 7505 
To amend the Internal Revenue Code of 1986 to add a new medical research 
component to the credit for increasing research activities. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 14, 2022 
Mr. BUCHANAN (for himself and Mr. KELLY of Pennsylvania) introduced the 
following bill; which was referred to the Committee on Ways and Means 
A BILL 
To amend the Internal Revenue Code of 1986 to add a 
new medical research component to the credit for in-
creasing research activities. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. NEW MEDICAL RESEARCH EXPENDITURE COM-
PONENT OF CREDIT FOR INCREASING RE-
SEARCH ACTIVITIES. 
(a) IN GENERAL.—Section 41(a) of the Internal Rev-
enue Code of 1986 is amended by striking ‘‘and’’ at the 
end of paragraph (2), by striking the period at the end 
of paragraph (3) and inserting ‘‘, and’’, and by adding 
at the end the following new paragraph: 
VerDate Sep 11 2014 
23:13 Apr 14, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7505.IH
H7505
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(4) 14 percent of specified medical research 
expenditures.’’. 
(b) SPECIFIED
MEDICAL
RESEARCH
EXPENDI-
TURES.—Section 41(f) of such Code is amended by adding 
at the end the following new paragraph: 
‘‘(7) SPECIFIED MEDICAL RESEARCH EXPENDI-
TURES.— 
‘‘(A) IN
GENERAL.—The term ‘specified 
medical research expenditures’ means amounts 
paid or incurred for qualified research with re-
spect to any qualified countermeasure. 
‘‘(B) QUALIFIED COUNTERMEASURE.—The 
term ‘qualified countermeasure’ has the mean-
ing given to such term in section 319F–1(a)(2) 
of the Public Health Service Act (42 U.S.C. 
247d–6a(a)(2)).’’. 
(c) DENIAL OF DOUBLE BENEFIT.— 
(1) TAXABLE YEARS BEGINNING BEFORE JANU-
ARY 1, 2022.—In the case of specified medical re-
search expenditures (as defined in section 41(f)(7) 
of such Code (as added by this section)) paid or in-
curred in taxable years beginning before January 1, 
2022— 
(A) such expenditures shall be treated in 
the same manner as qualified research expenses 
VerDate Sep 11 2014 
23:13 Apr 14, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7505.IH
H7505
pamtmann on DSKBC07HB2PROD with BILLS
and basic research expenses under section 
280C(c)(1) of such Code (as in effect on the 
day before the enactment of the Tax Cuts and 
Jobs Act), and 
(B) the amount determined under section 
280C(c)(2)(A) (as in effect on such day) for the 
taxable year shall be increased by the amount 
of credit determined for the taxable year under 
section 41(a)(4) (as added by this section). 
(2) TAXABLE YEARS BEGINNING AFTER DECEM-
BER 31, 2021.—Section 280C(c)(1) of such Code is 
amended by striking ‘‘section 41(a)(1)’’ and insert-
ing ‘‘paragraphs (1) and (4) of section 41(a)’’. 
(d) CONFORMING AMENDMENT.—Section 41(f)(1) of 
such Code is amended by striking ‘‘and amounts paid or 
incurred to energy research consortiums’’ each place it ap-
pears and inserting ‘‘, amounts paid or incurred to energy 
research consortiums, and specified medical research ex-
penditures’’. 
(e) EFFECTIVE DATE.—The amendments made by 
this section shall apply to amounts paid or incurred after 
the date of the enactment of this Act, in taxable years 
ending after such date. 
Æ 
VerDate Sep 11 2014 
23:13 Apr 14, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H7505.IH
H7505
pamtmann on DSKBC07HB2PROD with BILLS